Jubilant Ingrevia Share Price
680.30-10.25 (-1.48%)
-7.02% past 1 Year
News
Jubilant Ingrevia to acquire 40 percent in Zettaone Technologies India for expansion
Equity
JUBLINGREA
Jubilant Ingrevia board approves 40 percent stake purchase in Zettaone Technologies
Equity
JUBLINGREA
Jubilant Ingrevia ramps niacinamide, specialty chemicals and nutrition EBITDA mix
Equity
JUBLINGREA
Jubilant Ingrevia maintains FY27 EBITDA guidance amid expected sequential recovery
Equity
JUBLINGREA
Jubilant Ingrevia Q1 FY26 EBITDA jumps with improved margin performance
Equity
JUBLINGREA
Jubilant Ingrevia Q1 revenue rises year-on-year, indicating healthy topline momentum
Equity
JUBLINGREA
Jubilant Ingrevia Q1 consolidated net profit jumps sharply on YoY basis
Equity
JUBLINGREA
Jubilant Ingrevia Ltd.: Rs 16.70 Crores Nse Block Trade; For ~ 261,366 Shares, At Rs 638.85
Equity
JUBLINGREA
Incred Maintains Add On Rating on Jubilant Ingrevia, Cuts Target Price
Equity
JUBLINGREA
Jubilant Ingrevia informs about compliance report
Equity
JUBLINGREA
Jubilant Ingrevia guides for strong sequential growth in FY27 performance
Equity
JUBLINGREA
Jubilant Ingrevia outlines FY27 capex, reaffirms long-term growth and earnings targets
Equity
JUBLINGREA
Jubilant Ingrevia projects strong revenue ramp-up from new CDMO opportunities
Equity
JUBLINGREA
Jubilant Ingrevia outlines strong multi-business volume and new molecule pipeline
Equity
JUBLINGREA
Jubilant Ingrevia - Quaterly Results
Equity
JUBLINGREA
Jubilant Ingrevia reports Profit after tax of 105.22 Crores, in the March 2026 quarter
Equity
JUBLINGREA
Jubilant Ingrevia Q4 EBITDA grows year-on-year despite slight margin compression
Equity
JUBLINGREA
Jubilant Ingrevia reports higher Q4 revenue on year,
Equity
JUBLINGREA
Jubilant Ingrevia reports higher Q4 consolidated net profit year on year
Equity
JUBLINGREA
Jubilant Ingrevia zooms on acquiring 100% equity stake in Remidex Pharma
Equity
JUBLINGREA